Karolina Dzwonek

615 total citations
23 papers, 355 citations indexed

About

Karolina Dzwonek is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Karolina Dzwonek has authored 23 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Immunology. Recurrent topics in Karolina Dzwonek's work include Cancer Research and Treatments (5 papers), Studies on Chitinases and Chitosanases (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Karolina Dzwonek is often cited by papers focused on Cancer Research and Treatments (5 papers), Studies on Chitinases and Chitosanases (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Karolina Dzwonek collaborates with scholars based in Poland, Brazil and Netherlands. Karolina Dzwonek's co-authors include Izabela Figiel, Barbara Dymek, Maciej Wieczorek, Monika Lamparska‐Przybysz, Daria Zdżalik-Bielecka, M Zaremba, Anna Fiedorowicz, B Oderfeld-Nowak, Adam Gołȩbiowski and Roman Błaszczyk and has published in prestigious journals such as Brain Research, International Journal of Molecular Sciences and Journal of Hepatology.

In The Last Decade

Karolina Dzwonek

22 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karolina Dzwonek Poland 11 160 69 61 54 41 23 355
Jingshu Tang China 12 242 1.5× 58 0.8× 103 1.7× 49 0.9× 54 1.3× 23 438
Yuan Mi China 7 286 1.8× 52 0.8× 37 0.6× 34 0.6× 29 0.7× 14 402
Kumaran Shanmugasundaram United States 6 253 1.6× 43 0.6× 45 0.7× 42 0.8× 23 0.6× 7 425
Eiichi Nakai Japan 12 187 1.2× 112 1.6× 77 1.3× 56 1.0× 27 0.7× 37 494
Allison M. Manuel United States 13 240 1.5× 41 0.6× 43 0.7× 56 1.0× 16 0.4× 24 408
Xiaoxue Qin China 10 214 1.3× 63 0.9× 53 0.9× 94 1.7× 33 0.8× 21 356
Nitin Koul India 9 226 1.4× 70 1.0× 81 1.3× 16 0.3× 42 1.0× 9 407
Peipei Gong China 12 217 1.4× 50 0.7× 60 1.0× 72 1.3× 49 1.2× 31 411
Kevin Brady United Kingdom 13 242 1.5× 71 1.0× 160 2.6× 32 0.6× 38 0.9× 29 591
Zuzana Hoferová Czechia 12 137 0.9× 41 0.6× 27 0.4× 58 1.1× 14 0.3× 35 352

Countries citing papers authored by Karolina Dzwonek

Since Specialization
Citations

This map shows the geographic impact of Karolina Dzwonek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karolina Dzwonek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karolina Dzwonek more than expected).

Fields of papers citing papers by Karolina Dzwonek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karolina Dzwonek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karolina Dzwonek. The network helps show where Karolina Dzwonek may publish in the future.

Co-authorship network of co-authors of Karolina Dzwonek

This figure shows the co-authorship network connecting the top 25 collaborators of Karolina Dzwonek. A scholar is included among the top collaborators of Karolina Dzwonek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karolina Dzwonek. Karolina Dzwonek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sklepkiewicz, Piotr, Barbara Dymek, Agnieszka Zagożdżon, et al.. (2023). Inhibition of Macrophage-Specific CHIT1 as an Approach to Treat Airway Remodeling in Severe Asthma. International Journal of Molecular Sciences. 24(5). 4719–4719. 7 indexed citations
2.
Dymek, Barbara, Piotr Sklepkiewicz, Patrycja Nejman‐Gryz, et al.. (2022). Pharmacological Inhibition of Chitotriosidase (CHIT1) as a Novel Therapeutic Approach for Sarcoidosis. Journal of Inflammation Research. Volume 15. 5621–5634. 11 indexed citations
3.
Grzybowski, Marcin, Roman Błaszczyk, Bartłomiej Borek, et al.. (2022). OATD-02 Validates the Benefits of Pharmacological Inhibition of Arginase 1 and 2 in Cancer. Cancers. 14(16). 3967–3967. 21 indexed citations
4.
Yamani, Abdellah, Daria Zdżalik-Bielecka, Karolina Dzwonek, et al.. (2020). Discovery and optimization of novel pyrazole-benzimidazole CPL304110, as a potent and selective inhibitor of fibroblast growth factor receptors FGFR (1–3). European Journal of Medicinal Chemistry. 210. 112990–112990. 39 indexed citations
5.
Dymek, Barbara, et al.. (2020). Therapeutic efficacy of the chitotriosidase inhibitors in STAM model of non-alcoholic steatohepatitis. Journal of Hepatology. 73. S451–S451. 1 indexed citations
6.
Grzybowski, Marcin, Roman Błaszczyk, Bartłomiej Borek, et al.. (2019). Targeting ARG2 as a novel therapeutic approach for cancer. Annals of Oncology. 30. v793–v794. 5 indexed citations
7.
Dymek, Barbara, Karolina Dzwonek, Paweł Dobrzański, et al.. (2018). Late Breaking Abstract - Phase 1, first-in-human study of OATD-01, a dual chitinase inhibitor for the treatment of respiratory diseases. PA5228–PA5228. 2 indexed citations
8.
9.
Grzybowski, Marcin, Marcin Mazurkiewicz, Anna Gieryng, et al.. (2018). Abstract B003: Development of OAT-1746, a novel arginase 1 and 2 inhibitor for cancer immunotherapy. Molecular Cancer Therapeutics. 17(1_Supplement). B003–B003. 1 indexed citations
10.
Grzybowski, Marcin, Marcin Mazurkiewicz, Roman Błaszczyk, et al.. (2017). Development of OAT-1746, a novel arginase 1 and 2 inhibitor for cancer immunotherapy. Annals of Oncology. 28. v418–v418. 3 indexed citations
11.
Grzybowski, Marcin, Marcin Mazurkiewicz, Roman Błaszczyk, et al.. (2017). Novel dual arginase 1/2 inhibitor OATD-02 (OAT-1746) improves the efficacy of immune checkpoint inhibitors. Annals of Oncology. 28. xi20–xi21. 8 indexed citations
12.
Mazurkiewicz, Marcin, Roman Błaszczyk, Anna Sosnowska, et al.. (2017). Development of OAT-1746, a novel arginase 1 and 2 inhibitor for cancer immunotherapy. Annals of Oncology. 28. v418–v419. 3 indexed citations
13.
Dymek, Barbara, et al.. (2015). Differences in gene expression and alterations in cell cycle of acute myeloid leukemia cell lines after treatment with JAK inhibitors. European Journal of Pharmacology. 765. 188–197. 4 indexed citations
14.
Zdżalik-Bielecka, Daria, et al.. (2014). Activating mutations in ALK kinase domain confer resistance to structurally unrelated ALK inhibitors in NPM-ALK-positive anaplastic large-cell lymphoma. Journal of Cancer Research and Clinical Oncology. 140(4). 589–598. 26 indexed citations
15.
Dymek, Barbara, et al.. (2014). Epithelial–mesenchymal transition confers resistance to selective FGFR inhibitors in SNU-16 gastric cancer cells. Gastric Cancer. 19(1). 53–62. 53 indexed citations
16.
Mikuła, Michał, Paweł Gaj, Karolina Dzwonek, et al.. (2010). Comprehensive Analysis of the Palindromic Motif TCTCGCGAGA: A Regulatory Element of the HNRNPK Promoter. DNA Research. 17(4). 245–260. 36 indexed citations
17.
18.
Fiedorowicz, Anna, Izabela Figiel, M Zaremba, Karolina Dzwonek, & B Oderfeld-Nowak. (2007). The ameboid phenotype of NG2 (+) cells in the region of apoptotic dentate granule neurons in trimethyltin intoxicated mice shares antigen properties with microglia/macrophages. Glia. 56(2). 209–222. 25 indexed citations
19.
Figiel, Izabela & Karolina Dzwonek. (2006). TNFα and TNF receptor 1 expression in the mixed neuronal–glial cultures of hippocampal dentate gyrus exposed to glutamate or trimethyltin. Brain Research. 1131(1). 17–28. 51 indexed citations
20.
Dzwonek, Karolina. (2005). NG2 expressing cells in hippocampal cultures survive neurotoxic insult and retain the ability to divide. Acta Neurobiologiae Experimentalis. 65(2). 161–165. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jingshu Tang Breakdown of academic impact, for papers by Yuan Mi Breakdown of academic impact, for papers by Kumaran Shanmugasundaram Breakdown of academic impact, for papers by Eiichi Nakai Breakdown of academic impact, for papers by Allison M. Manuel Breakdown of academic impact, for papers by Xiaoxue Qin Breakdown of academic impact, for papers by Nitin Koul Breakdown of academic impact, for papers by Peipei Gong Breakdown of academic impact, for papers by Kevin Brady Breakdown of academic impact, for papers by Zuzana Hoferová
Rankless by CCL
2026